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Abstract
In whole-genome association studies, at the first stage, all markers are tested for association and
their test statistics or p-values are ranked. At the second stage, some most significant markers are
further analyzed by more powerful statistical methods. This helps reduce the number of
hypotheses to be corrected for in multiple testing. Ranks of true associations in genome-wide scans
using a single test statistic have been studied. In a case-control design for association, the trend test
has been proposed. However, three different trend tests, optimal for the recessive, additive, and
dominant models, respectively, are available for each marker. Because the true genetic model is
unknown, we rank markers based on multiple test statistics or test statistics robust to model mis-
specification. We studied this problem with application to Problem 3 of Genetic Analysis
Workshop 15. An independent simulation study was also conducted to further evaluate the
proposed procedure.
Background
For a large genetic study, a two-stage analysis is often
employed. At the first stage, each marker is tested for asso-
ciation with a disease. The p-values of all markers are
ranked. Then some of the most significant markers are
analyzed in the second stage. This two-stage analysis
reduces the number of hypotheses to be tested in the sec-
ond stage. Hence, it enhances the power to identify true
marker susceptibility to the disease. However, it is impor-
tant to know how many of the most significant markers
one should study in the second stage so that the probabil-
ity that one or several true markers will be studied in the
second stage is greater than a given value. On the other
hand, when a given number of the most significant mark-
ers is selected, it is important to know the probability that
this list of markers would contain one or more true mark-
ers. A small list of the most significant markers may not
contain any true markers at all, which leads to spurious
associations or negative findings in the second stage.
Zaykin and Zhivotovsky [1] used p-values of a single test
statistic to rank markers. In a case-control study for com-
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plex diseases, three trend tests can be applied under the
recessive, additive, and dominant models. Because the
genetic model of the marker is uncertain, ranking the
markers with a single test statistic may not be robust when
another genetic model is correct. Using the first simulated
data set of Problem 3 from Genetic Analysis Workshop
(GAW) 15, we study robust ranking when the underlying
genetic model is unknown and examine whether robust
test statistics would lead to robust rankings of about 10 K
single-nucleotide polymorphisms (SNPs). The properties
of the proposed robust ranking procedures are then fur-
ther examined by an independent simulation study.
Methods
Notation and model
Consider a SNP with alleles D and d and frequencies p and
q = 1 - p, respectively. In a case-control design, r cases and
s controls are independently sampled from a population.
The genotype counts of three genotypes G0 = dd, G1 = Dd,
and G2 = DD are denoted as (r0, r1, r2) in cases and (s0, s1,
s2) in controls, which follow multinomial distributions
mul(r: p0, p1, p2) and mul(s: q0, q1, q2), respectively. Denote
the disease prevalence as k  and penetrances as fi  =
P(case|Gi) for i = 0, 1, 2. By the Bayes Theorem, pi = gifi/k
and qi = gi(1 - fi)/(1 - k), where gi = P(Gi). Without loss of
generality, assume that D  has high risk. Then the null
hypothesis of no association can be stated as H0: f0 = f1 =
f2 = k. The alternative hypothesis is H1: f0 ≤ f1 ≤ f2 with at
least one inequality. The genotype relative risks (GRRs)
are defined as λ1 = f1/f0 and λ2 = f2/f0. The recessive, addi-
tive, and dominant models are referred to as λ1 = 1, λ1 = (1
+ λ2)/2, and λ1 = λ2, respectively [2-4].
Trend tests and robust tests
To test association using case-control data, the Cochran-
Armitage trend test (CATT) has been proposed [2-4],
which can be written as
where (x0, x1, x2) = (0, x, 1) and 0 ≤ x ≤ 1. Given x, Zx fol-
lows asymptotically N(0,1). The choice of x is 0, 1/2, and
1 for the recessive, additive/multiplicative, and dominant
models, respectively [5]. In practice, however, the true
genetic model is unknown. Hence the robust tests, max-
imin efficiency robust test (MERT) and maximum test
(MAX), can be applied, which are given by MERT = (Z0 +
Z1)/{2(1 + ρ)}1/2 and MAX = max(|Z0|, |Z1/2|, |Z1|), where
ρ = [n0n2/{(n0 + n1)(n1 + n2)}]1/2 [4]. Note that Pearson's
association test can also be used. However, Zheng et al. [6]
showed that the MAX is often more powerful than the
Pearson chi-squared test for a case-control design. Com-
parison of MERT and MAX can be found in Freidlin et al.
[7]. The MAX and MERT have also been applied to other
designs for GAW14 [8,9].
Ranking markers with multiple statistics
When the genetic model is unknown, the three CATTs (Z0,
Z1/2, Z2) are calculated for each of M SNPs. Then the p-val-
ues of MERT and MAX can be obtained for ranking. How-
ever, computing the p-value of MAX needs extensive
simulation. Thus, alternatively, the minimum of the p-val-
ues (min p) of the three CATTs can be used for ranking.
Rather than ranking M SNPs based on any single CATT,
we propose ranking the SNPs by the MERT and the mini-
mum of the p-values. We expect that ranking SNPs based
on this approach would be more robust compared to
ranking by a single CATT when the ranks by the three
CATTs are quite different.
Results
Application to GAW15
As an application, we consider the first simulated data set
of Problem 3 from GAW15. A simulated data set was con-
sidered, as we knew that there were eight candidate genes.
One of them at chromosome 6 with physical location
32,484,648 bp was simulated based on the DRB1 locus of
the HLA gene. We selected four SNPs closest in physical
distance to the eight known candidate genes as candidate
SNPs. We examined the ranks of the 32 candidate SNPs
among all 9187 SNPs. All 2000 unrelated controls were
used. For the affected sib-pair (ASP) data, we selected an
affected sib (case) with the first individual ID from each
family. A total of 1500 unrelated cases were used. In the
simulated data set, genotypes of all 9187 SNPs from 22
chromosomes were generated (no missing genotypes and
no genotyping errors). All SNPs had minor allele fre-
quency (MAF) greater than 1% and there were no mono-
morphisms. Because we considered the CATTs, Hardy-
Weinberg equilibrium in the population was not required
[2]. If any genotype count in cases or controls was 0, 0.5
was added to all genotype counts in cases and controls.
After Bonferroni correction for Z0 (Z1/2 and Z1), there were
5 (7 and 7) SNPs among the 32 candidate SNPs that had
Bonferroni-corrected  p-values less than 0.05. All three
CATTs, the MERT, and the minimum of the p-values of the
three CATTs were used to rank all 9187 SNPs. The ranks of
the 32 candidate SNPs are reported in Table 1 by five dif-
ferent ranking methods. The results are summarized
below: 1) in the candidate gene DRB1 of HLA (chromo-
some 6, location = 32,484,648), four of the six most sig-
nificant candidate SNPs are in this region. This implies
that when the sample size and a genetic effect are large, a
strong candidate gene should contain several SNPs at the
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top of the list of most significant SNPs. 2) Using a single
CATT to rank SNPs may not be robust, and using MERT or
the minimum p-value is more robust. For example, the
SNP (chromosome 6, location = 37,363,880) has rank of
6 using either Z1/2 or Z1, and 8172 when Z0 is used. But the
ranks of this SNP by MERT and minimum p-value are 10
and 6, respectively. 3) When the ranks by the three CATTs
are quite different, the ranks by the robust methods are
usually in the middle. 4) With a sample size of 3500,
some candidate SNPs have ranks larger than those of null
SNPs. Thus, selecting only the most significant SNPs from
the genome-wide scan for further analysis may exclude
some true associations or candidate genes. This informa-
tion is particularly important for cost-efficient two-stage
design for genome-wide association studies (e.g., Skol et
al. [10]) in which only a portion of samples will be geno-
typed in the first stage to select markers to be genotyped
using the remaining samples.
An independent simulation study
To further study the properties of the robust ranking pro-
cedures, we conducted an independent simulation study.
We simulated a case-control genome-wide association
study of 100,000 SNPs with 500 cases and 500 controls.
For illustration, we simply assumed that all SNPs were in
linkage equilibrium, among which 9 SNPs were associ-
ated with a disease (3 SNPs had recessive, additive, and
dominant modes of inheritance, respectively). The MAFs
for the recessive, additive, and dominant SNPs were set at
0.3. MAFs for other null SNPs were generated from a uni-
form distribution (0, 1). The GRRs for each genetic model
were specified. We repeated simulations of 100 K SNPs
ten times and the average ranks for the 9 candidate SNPs
were obtained and reported in Table 2. As in Table 1, min
p and MERT are more robust than a single trend test (Z0,
Z1/2, or Z1) for genome-wide scans. For example, for SNPs
3, 6, and 9 (having the greatest GRRs for each genetic
Table 1: Ranks of candidate genes among 9187 SNPs across 22 chromosomes based on five ranking methods, sorted by chromosome 
and location
Rank
Chr Location (bp) Diffa Z0 Z1/2 Z1 min p MERT
6 32447149 37 kb 4 4 4 3 4
6 32499465 14 kb 2 2 2 1 2
6 32521277 36 kb 3 3 3 2 3
6 32772203 387 kb 5 5 5 4 5
6 36900959 330 kb 966 1190 2028 1881 647
6 37363880 130 kb 8172 6 6 6 10
6 37539191 300 kb 6359 1430 464 931 2897
6 37657759 423 kb 968 1341 4671 1884 1414
8 140606402 3.2 mb 3012 4237 5775 5167 3328
8 140676097 3.1 mb 8391 7443 7097 8726 7382
8 140679773 3.1 mb 7936 7288 7096 8727 7225
8 142073109 1.7 mb 8918 6991 6588 8459 7407
9 25996861 262 kb 2921 4074 6290 5039 3556
9 26089466 169 kb 2179 9009 4702 3930 6948
9 26484252 225 kb 2374 2254 4205 3889 2291
9 26521692 262 kb 2909 2113 2819 3677 1947
9 27418665 118 kb 3667 3963 6458 5915 4070
9 27505967 31 kb 6228 7286 8222 8279 7989
9 27697461 160 kb 5582 7177 5317 7490 8915
9 27697600 160 kb 5195 4841 3323 5329 7532
11 110204257 30 kb 1 1 1 5 1
11 110259778 24 kb 3492 3162 4276 5125 2930
11 110264385 29 kb 271 222 857 419 186
11 110322303 87 kb 6840 3492 1930 3411 3030
16 12527182 9 kb 7729 4194 4148 6328 4884
16 12577812 60 kb 4288 5913 4696 6589 8924
16 12618035 100 kb 6212 7783 8356 8266 6771
16 12783679 266 kb 5824 4802 5334 7101 4733
18 65844474 225 kb 6522 4959 5282 7254 4864
18 66045171 24 kb 7063 8720 9182 8750 7913
18 66048927 20 kb 15 15 15 15 13
18 66230498 160 kb 5441 6135 6872 7732 5409
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model), the ranks of min p and MERT across three genetic
models are all on the list of top 100 most significant SNPs,
but are not if any single trend test is used.
Conclusion
In this article, we studied the robust properties of ranks of
true associations in genome-wide scans. In some situa-
tions, ranking markers by a single trend test may not be
robust, in particular, when the true genetic model is
unknown. Using robust methods, such as min p  and
MERT, to rank markers may lead to higher power when
the ranks by three CATTs are quite different. The results
showed that they are particularly useful in ensuring that
recessive effects are not missed. While min p and MERT
improve the univariate approach to the first stage of gene
discovery, simulated data shows that some SNPs are not
found via these univariate methods.
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